Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions

QR Code

Three-year results of a modified photodynamic therapy procedure (Ironing PDT) for age-related macular degeneration patients with large lesions

Tsuyoshi Otsuji,1 Kenichiro Sho,2 Akiko Tsumura,1 Naoko Koike,1 Tetsuya Nishimura,1 Kanji Takahashi2 1Department of Ophthalmology, Kansai Medical University, Takii Hospital, 2Department of Ophthalmology, Kansai Medical University, Hirakata Hospital, Osaka, Japan Background: To evaluate the effect...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Otsuji T, Sho K, Tsumura A, Koike N, Nishimura T, Takahashi K
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2016
Sujets:	AMD PDT Ironing PDT Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/b970113aa8934c86b8d8f8ff8f1b87d9
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Treatment of large avascular retinal pigment epithelium detachments in age-related macular degeneration with aflibercept, photodynamic therapy, and triamcinolone acetonide
par: Tvenning AO, et autres
Publié: (2019)

Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
par: Koike N, et autres
Publié: (2019)

Pathological Mechanism of Photodynamic Therapy and Photothermal Therapy Based on Nanoparticles
par: Hou Y, et autres
Publié: (2020)

Malachite green-conjugated multi-walled carbon nanotubes potentiate antimicrobial photodynamic inactivation of planktonic cells and biofilms of Pseudomonas aeruginosa and Staphylococcus aureus
par: Anju VT, et autres
Publié: (2019)

Ultrasmall AGuIX theranostic nanoparticles for vascular-targeted interstitial photodynamic therapy of glioblastoma
par: Thomas E, et autres
Publié: (2017)

Photodynamic Therapy Using Toluidine Blue O (TBO) Dye as a Photosensitizer against Leishmania major
par: Mehdi Najm, et autres
Publié: (2021)

Functional chlorin gold nanorods enable to treat breast cancer by photothermal/photodynamic therapy
par: Liu L, et autres
Publié: (2018)

Curcumin-loaded nanostructured lipid carriers prepared using Peceol™ and olive oil in photodynamic therapy: development and application in breast cancer cell line
par: Kamel AE, et autres
Publié: (2019)

Use of Polyhedral Oligomeric Silsesquioxane (POSS) in Drug Delivery, Photodynamic Therapy and Bioimaging
par: Paula Loman-Cortes, et autres
Publié: (2021)

Folate-mediated and pH-responsive chidamide-bound micelles encapsulating photosensitizers for tumor-targeting photodynamic therapy
par: Ma Z, et autres
Publié: (2019)

Killing malignant melanoma cells with protoporphyrin IX-loaded polymersome-mediated photodynamic therapy and cold atmospheric plasma
par: Wang M, et autres
Publié: (2017)

X-ray radiation-induced and targeted photodynamic therapy with folic acid-conjugated biodegradable nanoconstructs
par: Clement S, et autres
Publié: (2018)

Targeted Photodynamic Diagnosis and Therapy for Esophageal Cancer: Potential Role of Functionalized Nanomedicine
par: Onyisi Christiana Didamson, et autres
Publié: (2021)

Antimicrobial photodynamic activity and cytocompatibility of Au25(Capt)18 clusters photoexcited by blue LED light irradiation
par: Miyata S, et autres
Publié: (2017)

Chronic central serous chorioretinopathy: long-term follow-up and vision-related quality of life
par: Breukink MB, et autres
Publié: (2016)

Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
par: Otsuji T, et autres
Publié: (2013)

Early and intermediate age-related macular degeneration: update and clinical review
par: García-Layana A, et autres
Publié: (2017)

Cone photoreceptor macular function and recovery after photostress in early non-exudative age-related macular degeneration
par: Rodriguez JD, et autres
Publié: (2018)

Ranibizumab in neovascular age-related macular degeneration: a 5-year follow-up
par: Cvetkova NP, et autres
Publié: (2016)

OCT Angiography-based Evaluation of the Choriocapillaris in Neovascular Age-related Macular Degeneration
par: Varsha Pramil, et autres
Publié: (2021)

Differential Circulating MicroRNA Expression in Age-Related Macular Degeneration
par: Hanan ElShelmani, et autres
Publié: (2021)

Annihilation of Leishmania by daylight responsive ZnO nanoparticles: a temporal relationship of reactive oxygen species-induced lipid and protein oxidation
par: Nadhman A, et autres
Publié: (2016)

Correlation of Baseline Visual Acuity with Outcomes of Treatment with Anti-VEGF in Neovascular Age-Related Macular Degeneration
par: Veluswamy B, et autres
Publié: (2020)

The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey
par: Varano M, et autres
Publié: (2016)

Randomised, Double-blind, Comparative Clinical Study of New Ranibizumab Biosimilar in Neovascular (Wet) Age-Related Macular Degeneration
par: Apsangikar P, et autres
Publié: (2021)

Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis
par: Cui C, et autres
Publié: (2017)

Aqueous humor cytokine levels through microarray analysis and a sub-analysis based on optical coherence tomography in wet age-related macular degeneration patients
par: Jin-Ho Joo, et autres
Publié: (2021)

Three-year follow-up of ranibizumab treatment of wet age-related macular degeneration: influence of baseline visual acuity and injection frequency on visual outcomes
par: Razi F, et autres
Publié: (2016)

Improving Outcomes for Patients with Age-Related Macular Degeneration and Cataracts: The Importance of Including an Assessment of Activities of Daily Life (ADL)
par: Borkenstein AF, et autres
Publié: (2021)

Comparing Effectiveness of Three Different Anti-VEGF Treatment Regimens for Neovascular Age-Related Macular Degeneration: Two Years’ Real-World Clinical Outcomes
par: Horner F, et autres
Publié: (2021)

Visual outcome of intravitreal ranibizumab for exudative age-related macular degeneration: timing and prognosis
par: Canan H, et autres
Publié: (2014)

Understanding COVID-19 Pandemic: Molecular Mechanisms and Potential Therapeutic Strategies. An Evidence-Based Review
par: Hanna R, et autres
Publié: (2021)

Effect of photodynamic therapy (PDT), posterior subtenon injection of triamcinolone acetonide with PDT, and intravitreal injection of ranibizumab with PDT for retinal angiomatous proliferation
par: Negi A, et autres
Publié: (2012)

Medication Trends for Age-Related Macular Degeneration
par: Yeon-Kyoung Cho, et autres
Publié: (2021)

Age, sex, and type of medication predict the effect of anti-VEGF treatment on central retinal thickness in wet age-related macular degeneration
par: Bek T, et autres
Publié: (2018)

No improvement in injection frequency or in visual outcome over time in two cohorts of patients from the same Swedish county treated for wet age-related macular degeneration
par: Schroeder M, et autres
Publié: (2017)

Investigation of associations of ARMS2, CD14, and TLR4 gene polymorphisms with wet age-related macular degeneration in a Greek population
par: Sarli A, et autres
Publié: (2017)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
par: Pongsachareonnont P, et autres
Publié: (2018)

Initiation and maintenance of a Treat-and-Extend regimen for ranibizumab therapy in wet age-related macular degeneration: recommendations from the UK Retinal Outcomes Group
par: Amoaku W, et autres
Publié: (2018)

Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration
par: Garweg JG
Publié: (2019)